Form 4: Arcellx Director Lubner Acquires Stock Options
SEC Form 4
Director David Charles Lubner acquired stock options in Arcellx, Inc. on May 28, 2024.
Summary
- On May 28, 2024, David Charles Lubner, a director of Arcellx, Inc., acquired stock options to purchase 8,011 shares of common stock at an exercise price of $51.30 per share.
- The options vest on the earlier of May 28, 2025, or the next annual meeting of stockholders, contingent upon Lubner's continued service as a Service Provider.
- Following the transaction, Lubner directly owns 8,011 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants to a director, which is neither particularly positive nor negative on its own.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in the biotechnology industry where equity compensation is frequently used.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of director confidence.
Key Dates
| Date | Description |
|---|---|
| 05/28/2024 | Date of stock option grant. |
| 05/28/2025 | Earliest vesting date for the stock options. |
| 06/06/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.